Why a GOP argument about unemployment insurance probably doesn't make much sense


Sens. Tim Scott (R-S.C.), Lindsey Graham (R-S.C.), and Ben Sasse (R-Neb.) said Wednesday they may oppose fast-tracking the Senate's coronavirus stimulus package because they fear that it could incentivize layoffs, as well as entice people to quit their jobs because they could make actually make more money from the enhanced unemployment insurance.
The argument angered some people, like Sen. Bernie Sanders (I-Vt.), who is threatening to hold up the bill until there are stronger protections from workers unless the GOP senators drop their objections. But others were left scratching their heads.
People are typically only eligible for unemployment benefits if they lose their jobs through no fault of their own. There are exceptions, of course, but generally speaking people who quit would need to show they had "good cause" for doing so to qualify for financial assistance.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
August 24 editorial cartoons
Cartoons Sunday's political cartoons include Putin at Donald Trump's circus, gallons of whitewash, and a foldable cartoon
-
5 Post Office-approved cartoons about mail-in voting
Cartoons Artists take on reverse logic, Putin's election advice, and more
-
The battle of the weight-loss drugs
Talking Point Can Novo Nordisk and Eli Lilly regain their former stock market glory? A lot is riding on next year's pills
-
New York court tosses Trump's $500M fraud fine
Speed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year